vasorel trimetazidine hydrochloride tablet 20mg per tablet 30tablets per carton

Description

Indication & Scope

VASOREL® is a prescription metabolic antianginal agent indicated as add-on therapy for the symptomatic treatment of adults with stable angina pectoris whose symptoms are inadequately controlled by, or who are intolerant to, first-line antianginal therapies. It is intended for long-term prevention of angina attacks and should not be used for acute angina or acute coronary syndrome. It may also be used in selected patients as supportive therapy for vertigo and tinnitus associated with inner ear ischemia, according to approved local labeling.

Mechanism: Trimetazidine selectively inhibits long-chain 3-ketoacyl-CoA thiolase, shifting myocardial energy metabolism from fatty acid oxidation to glucose oxidation, thereby improving ATP production during ischemia without affecting heart rate or blood pressure.
Drug class: Metabolic antianginal agent.
Clinical use: Long-term management of stable angina in adults with insufficient response or intolerance to conventional antianginal therapy.

Specification

Generic Name	Trimetazidine Hydrochloride Tablets
Brand Name	VASOREL®
Ingredient	Trimetazidine Hydrochloride
Dosage Form	Tablet
Package	20 mg/tablet, 30 tablets/carton
Conditions Treated	Stable angina pectoris; supportive treatment of ischemia-related vertigo and tinnitus
Taboos	Hypersensitivity to trimetazidine; Parkinson’s disease, parkinsonian symptoms, tremor, restless legs syndrome or other movement disorders; severe renal impairment (eGFR <30 mL/min/1.73 m²); breastfeeding
Place of origin	China
Prescription type	Prescription Drug (Rx)
Storage Conditions	Store below 30°C in a dry place, protected from light.
Manufacturer	Servier (Tianjin) Pharmaceutical Co., Ltd.
Registration Authority	National Medical Products Administration (NMPA), China
Approval Number	H20055465
Approval Date	August 12, 2024
Shelf Life	36 months

How to use ?

Recommended Dose: The recommended dose is 20 mg three times daily, taken with meals. Patients with moderate renal impairment may require dose reduction according to the approved prescribing information.

Time: Take during meals, preferably at the same times each day.

Instructions for use: Swallow the tablet whole with water. Continue treatment only under medical supervision. This medicine is not intended for the relief of acute angina attacks.

Interaction: No clinically significant drug interactions have been established. Trimetazidine may be used together with standard cardiovascular therapies, including aspirin, statins, nitrates, beta-blockers, and calcium channel blockers, as clinically indicated.

Side effects: Common adverse reactions include nausea, vomiting, abdominal discomfort, dizziness, headache, and fatigue. Rare but important adverse effects include Parkinsonian symptoms, tremor, gait instability, and restless legs syndrome, which generally improve after discontinuation.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support